Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
20 hedge funds and large institutions have $9.75M invested in Biocept, Inc. in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 5 closing their positions.
1,082% more capital invested
Capital invested by funds: $825K → $9.75M (+$8.93M)
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
5% more funds holding
Funds holding: 19 → 20 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.87M |
| 2 |
BlackRock
New York
|
+$1.18M |
| 3 |
Renaissance Technologies
New York
|
+$943K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$118K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$111K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$63K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$35.9K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$12K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$9K |
| 5 |
HF
HRT Financial
New York
|
-$8K |
BIOC Hedge Fund Activity: Q2 2020 in Review
20 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q2 2020, worth a combined $9.75M — up 1,082% from $825K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new BIOC positions and 5 closed out — a net gain of 1 holder — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $2.87M. The largest seller was Barclays, exiting entirely with an estimated $63K sold.
- 20 institutional investors held Biocept, Inc. (BIOC) as of Q2 2020, up from 19 in Q1 2020.
- Funds reported $9.75M of Biocept, Inc. stock for Q2 2020, up 1,082% quarter-over-quarter.
- 6 funds opened new Biocept, Inc. positions in Q2 2020 and 5 closed out, a net change of +1 holder.
- The largest Biocept, Inc. buyer in Q2 2020 was Vanguard Group, an estimated $2.87M added.
- The largest Biocept, Inc. seller in Q2 2020 was Barclays, an estimated $63K sold.
Based on aggregated 13F filings for Q2 2020.